Company Valuation: Amgen Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 126,718 140,139 154,142 140,103 176,250 251,940 - -
Change - 10.59% 9.99% -9.11% 25.8% 42.94% - -
Enterprise Value (EV) 1 151,990 169,779 207,811 188,229 221,725 293,297 287,244 282,372
Change - 11.7% 22.4% -9.42% 17.8% 32.28% -2.06% -1.7%
P/E 21.9x 21.7x 23.1x 34.5x 23x 29.6x 26.3x 25.1x
PBR 18.7x 38.3x 24.7x 23.8x 20.4x 22.5x 18.3x 14.7x
PEG - 1.2x 7.36x -0.9x 0.3x 2.7x 2.2x 5.2x
Capitalization / Revenue 4.88x 5.32x 5.47x 4.19x 4.8x 6.46x 6.24x 6.01x
EV / Revenue 5.85x 6.45x 7.37x 5.63x 6.03x 7.53x 7.11x 6.74x
EV / EBITDA 9.61x 10.5x 11.9x 9.13x 10.4x 13.5x 12.9x 12.7x
EV / EBIT 12.2x 13.3x 15.5x 12.5x 13.7x 17.3x 16.2x 15.2x
EV / FCF 18.1x 19.3x 28.2x 18.1x 27.4x 24.8x 18x 17.8x
FCF Yield 5.51% 5.17% 3.54% 5.52% 3.65% 4.04% 5.57% 5.61%
Dividend per Share 2 7.04 7.76 8.52 9 9.52 10.09 10.66 11.12
Rate of return 3.13% 2.95% 2.96% 3.45% 2.91% 2.16% 2.29% 2.39%
EPS 2 10.28 12.11 12.49 7.56 14.23 15.77 17.69 18.54
Distribution rate 68.5% 64.1% 68.2% 119% 66.9% 64% 60.2% 60%
Net sales 1 25,979 26,323 28,190 33,424 36,751 38,975 40,398 41,904
EBITDA 1 15,822 16,178 17,470 20,620 21,370 21,765 22,232 22,226
EBIT 1 12,424 12,761 13,399 15,028 16,203 16,955 17,779 18,560
Net income 1 5,893 6,552 6,717 4,090 7,711 8,559 9,439 10,072
Net Debt 1 25,272 29,640 53,669 48,126 45,475 41,357 35,304 30,432
Reference price 2 224.97 262.64 288.02 260.64 327.31 466.01 466.01 466.01
Nbr of stocks (in thousands) 563,266 533,579 535,178 537,533 538,481 540,632 - -
Announcement Date 2/7/22 1/31/23 2/6/24 2/4/25 2/3/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
29.56x7.53x13.48x2.16% 252B
41.54x14.06x31.11x0.48% 1,263B
39.99x6.71x18.89x1.95% 658B
38.61x8.62x17.83x2.33% 521B
21.74x5.27x13.12x2.48% 391B
109.15x6.06x25.73x2.28% 369B
23.19x5.97x14.41x2.71% 307B
24.47x4.9x13.63x1.77% 290B
-49.1x7.47x29.35x1.93% 212B
11.64x4.27x8.77x4.32% 176B
Average 29.08x 7.09x 18.63x 2.24% 443.77B
Weighted average by Cap. 36.27x 8.66x 21.44x 1.8%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Amgen Inc.

Historical PBR trend

Valuation ratios - PBR - Amgen Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Amgen Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Amgen Inc.


Year-on-year evolution of the Yield

Valuation ratios - Yield - Amgen Inc.
  1. Stock Market
  2. Stocks
  3. AMGN Stock
  4. Valuation Amgen Inc.